2 - Network organisation and process
Quality
Management |
Training and
Education |
Public
Involvement |
Description | ||
---|---|---|
Name |
TREAT-NMD - Neuromuscular Network |
|
Existence of an identified contact person for external enquiries | Yes | |
Existence of an internal steering committee | Yes | Annemieke Aartsma-Rus (Leiden University Medical Centre, The Netherlands) Eric Hoffman (Vice Chair) (Children’s National Medical Centre, USA) Filippo Buccella (Parent Project Onlus, Italy) Vice-Chair Kevin Flanigan (Ohio State University, USA) - Chair Janbernd Kirschner (University Medical Centre Freiburg, Germany) Eugenio Mercuri (Università Cattolica del Sacro Cuore, Italy) Ichizo Nishino (National Center of Neurology and Psychiatry, Japan) Jes Rahbek (The Rehabilitation Centre for Neuromuscular Diseases, Denmark) 160 Thomas Sejersen (Karolinska Institute, Sweden) J. Andoni Urtizberea (Hôpital Marin de Hendaye - France) |
Existence of an external advisory steering committee directing the reporting party | Yes | TREAT-NMD strategic activities are overseen by an external Executive Committee. |
Existence of a website | Yes | www.treat-nmd.eu |
Existence of newsletter | Yes | Electronic email newsletter distributed to around 3,500 stakeholders |
Existence of internal databases for disease, condition treatment and/or outcome | Yes | |
Provisions to ascertain data protection and data security | Yes | Please see the link: http://www.treat-nmd.eu/downloads/file/TGDOC_Charter_2016.pdf |
Procedures to access the database by third parties | Yes | Access to data (TREAT-NMD Global Registries) is governed by a Charter and the TREAT-NMD Global Database Oversight Committee (TGDOC). |
Access to external databases/registries | Yes | |
Standardised process to access an external database | No | The TREAT-NMD Global Registries are governed by a Charter and the TREAT-NMD Global Database Oversight Committee (TGDOC). Researchers and pharmaceutical companies interested in locating patients for a clinical trial are able to request information from the TREAT-NMD Global Registry meaning that they can speedily find the information they need. |